Taras Omelchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taras Omelchenko has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Oleksandr Buryanov
Bogomolets National Medical University, Kyiv, Ukraine
27 shared publications - Olena Turchin
Institute of traumatology and orthopaedics of National Academy of Medical Sciences of Ukraine
12 shared publications - Liudmyla Khimion
Shupyk National Healthcare University of Ukraine
9 shared publications - Andrii P. Liabakh
Institute of traumatology and orthopaedics of National Academy of Medical Sciences of Ukraine
5 shared publications - H.S. Tsapenko
Bogomolets National Medical University, Kyiv, Ukraine
4 shared publications - Volodymyr Lianskorunskyi
Bogomolets National Medical University, Kyiv, Ukraine
4 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Publishing House Zaslavsky in TRAUMA
- Vol. 27 (5) , 458-464
Treatment of patients with critical tibial defects complicated by osteomyelitis using the Masquelet technique and distraction osteosynthesis
Background. The Masquelet technique (induced membrane technique) and distraction osteogenesis using the Ilizarov method are well-recognized methods for the treatment of patients with segmental defects of the tibia associated with chronic osteomyelitis. There are no direct comparative studies in the domestic literature, and in the international literature, there are only a fairly limited number of publications with a small number of patients in groups. The purpose was to conduct a comparative retrospective analysis of clinical outcomes when using the Masquelet technique and the Ilizarov method in the treatment of critical tibial defects complicated by osteomyelitis. Materials and methods. A total of 167 patients with critical defects of the tibia complicated by osteomyelitis were treated. After applying the inclusion and exclusion criteria, two groups were formed: the first one, Masquelet group, comprised 39 patients with exclusively combat-related injuries, while the second one, the Ilizarov group, included 47 patients with both combat- and non-combat-related injuries. Results and conclusions. The Masquelet technique and the Ilizarov method are effective treatments for critical tibial defects complicated by osteomyelitis, with consolidation rates of 97.4 and 100 %, respectively. The Masquelet technique results in significantly shorter healing times (168.08 ± 62.00 vs. 258.18 ± 157.16 days, p < 0.001), representing a 90-day (3-month) advantage. This advantage was confirmed in a stratified analysis in the 4–6-cm (p = 0.002) and 6–9-cm (p = 0.008) subgroups. The presence of Klebsiella pneumoniae or Pseudomonas aeruginosa is an unfavorable microbiological predictor of consolidation duration, regardless of the method chosen (p < 0.05), and may require repeat surgical debridement and combined targeted antibiotic therapy. Assessment using the ASAMI scale revealed no statistically significant difference between the methods in terms of bone outcomes (92.3 vs. 83.3 %; p = 0.210). Functional outcomes show a trend in favor of the Masquelet technique (94.9 vs. 83.3 %; p = 0.093).
- 22 October 2026
- Published by Publishing House Zaslavsky in TRAUMA
- Vol. 27 (5) , 458-464
Open AccessTreatment of patients with critical tibial defects complicated by osteomyelitis using the Masquelet technique and distraction osteosynthesis
Background. The Masquelet technique (induced membrane technique) and distraction osteogenesis using the Ilizarov method are well-recognized methods for the treatment of patients with segmental defects of the tibia associated with chronic osteomyelitis. There are no direct comparative studies in the domestic literature, and in the international literature, there are only a fairly limited number of publications with a small number of patients in groups. The purpose was to conduct a comparative retrospective analysis of clinical outcomes when using the Masquelet technique and the Ilizarov method in the treatment of critical tibial defects complicated by osteomyelitis. Materials and methods. A total of 167 patients with critical defects of the tibia complicated by osteomyelitis were treated. After applying the inclusion and exclusion criteria, two groups were formed: the first one, Masquelet group, comprised 39 patients with exclusively combat-related injuries, while the second one, the Ilizarov group, included 47 patients with both combat- and non-combat-related injuries. Results and conclusions. The Masquelet technique and the Ilizarov method are effective treatments for critical tibial defects complicated by osteomyelitis, with consolidation rates of 97.4 and 100 %, respectively. The Masquelet technique results in significantly shorter healing times (168.08 ± 62.00 vs. 258.18 ± 157.16 days, p < 0.001), representing a 90-day (3-month) advantage. This advantage was confirmed in a stratified analysis in the 4–6-cm (p = 0.002) and 6–9-cm (p = 0.008) subgroups. The presence of Klebsiella pneumoniae or Pseudomonas aeruginosa is an unfavorable microbiological predictor of consolidation duration, regardless of the method chosen (p < 0.05), and may require repeat surgical debridement and combined targeted antibiotic therapy. Assessment using the ASAMI scale revealed no statistically significant difference between the methods in terms of bone outcomes (92.3 vs. 83.3 %; p = 0.210). Functional outcomes show a trend in favor of the Masquelet technique (94.9 vs. 83.3 %; p = 0.093).
- Open Access
- 7 October 2026
- Published by Orthopaedica, Traumatology, and Prosthetics in ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS
- No. 3,p. 157-166
INTRA-ARTICULAR ADMINISTRATION OF AUTOLOGOUS AND ALLOGENEIC MESENCHYMAL STROMAL CELLS FOR KNEE OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL STUDIES
Objective. To evaluate the efficacy and safety of intra-articular administration of autologous and allogeneic mesenchymal stromal cells in the treatment of knee osteoarthritis based on a systematic review and meta-analysis of clinical studies. Methods. A systematic review and meta-analysis were conducted in accordance with the PRISMA 2020 principles. The literature search was performed in PubMed, Scopus, Web of Science, and Cochrane Library databases for the period from 2010 to 2025. The qualitative analysis included 11 clinical studies evaluating the efficacy and/or safety of intra-articular mesenchymal stromal cell administration in patients with knee osteoarthritis. Results. The VAS meta-analysis included 4 controlled studies with a total of 87 participants, while the WOMAC metaanalysis included 3 controlled studies with a total of 67 participants. Intra-articular administration of mesenchymal stromal cells was associated with a statistically significant reduction in pain intensity according to the VAS score: SMD = −1.09; 95 % CI: −1.81 to −0.36; p = 0.003; I² = 56 %. A statistically significant improvement in functional status according to the WOMAC score was also observed: S MD = −0.62; 95 % CI: −1.19 to −0.05; p = 0.03; I ² = 22 %. In most included studies, mesenchymal stromal cell therapy was well tolerated. The most commonly reported adverse events were transient local pain, swelling, or mild synovitis after injection. Conclusions. Intra-articular administration of mesenchymal stromal cells may represent a promising biological approach for the treatment of knee osteoarthritis, as it is associated with pain reduction and functional improvement.
- 7 October 2026
- Published by Orthopaedica, Traumatology, and Prosthetics in ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS
- No. 3,p. 157-166
Open AccessINTRA-ARTICULAR ADMINISTRATION OF AUTOLOGOUS AND ALLOGENEIC MESENCHYMAL STROMAL CELLS FOR KNEE OSTEOARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL STUDIES
Objective. To evaluate the efficacy and safety of intra-articular administration of autologous and allogeneic mesenchymal stromal cells in the treatment of knee osteoarthritis based on a systematic review and meta-analysis of clinical studies. Methods. A systematic review and meta-analysis were conducted in accordance with the PRISMA 2020 principles. The literature search was performed in PubMed, Scopus, Web of Science, and Cochrane Library databases for the period from 2010 to 2025. The qualitative analysis included 11 clinical studies evaluating the efficacy and/or safety of intra-articular mesenchymal stromal cell administration in patients with knee osteoarthritis. Results. The VAS meta-analysis included 4 controlled studies with a total of 87 participants, while the WOMAC metaanalysis included 3 controlled studies with a total of 67 participants. Intra-articular administration of mesenchymal stromal cells was associated with a statistically significant reduction in pain intensity according to the VAS score: SMD = −1.09; 95 % CI: −1.81 to −0.36; p = 0.003; I² = 56 %. A statistically significant improvement in functional status according to the WOMAC score was also observed: S MD = −0.62; 95 % CI: −1.19 to −0.05; p = 0.03; I ² = 22 %. In most included studies, mesenchymal stromal cell therapy was well tolerated. The most commonly reported adverse events were transient local pain, swelling, or mild synovitis after injection. Conclusions. Intra-articular administration of mesenchymal stromal cells may represent a promising biological approach for the treatment of knee osteoarthritis, as it is associated with pain reduction and functional improvement.
- Open Access
- 11 September 2026
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 6,p. 182-190
CHRONIC ANKLE INSTABILITY: A REVIEW OF MODERN APPROACHES TO DIAGNOSIS AND TREATMENT
Introduction. Ligamentous injuries of the ankle joint are among the most common sports- and work-related musculoskeletal injuries. Despite advances in the management of acute ankle sprains, 25–40% of patients subsequently develop chronic ankle instability (CAI). This condition is characterized by recurrent ankle sprains, persistent pain, reduced range of motion, and impaired proprioception, resulting in functional limitations and highlighting the need for a well-defined diagnostic and therapeutic approach.Aim. To conduct a comprehensive analysis of current scientific evidence regarding the pathophysiological mechanisms, differential diagnostic criteria, and clinical outcomes of conservative and surgical treatment strategies for patients with chronic post-traumatic ankle instability.Materials and methods. This review analyzes the anatomical and biomechanical characteristics of the lateral ligament complex, including the anterior talofibular (ATFL), calcaneofibular (CFL), and posterior talofibular (PTFL) ligaments. It also examines the physiological basis for classifying CAI into mechanical instability (structural ligament insufficiency) and functional instability (neuromuscular deficits and impaired coordination).Results. Comprehensive clinical evaluation should combine specific manual stress tests with advanced imaging modalities. Ultrasonography and magnetic resonance imaging demonstrate high diagnostic accuracy for assessing ligament integrity and detecting associated intra-articular lesions, including synovitis, osteochondral defects, and impingement syndrome. A differentiated treatment strategy is recommended: structured conservative rehabilitation lasting at least 3 months is effective for patients with functional instability, whereas persistent mechanical instability requires surgical stabilization. Surgical techniques have evolved from the conventional open Broström–Gould procedure to contemporary minimally invasive arthroscopic repair and synthetic tape augmentation.Conclusions. Chronic ankle instability is a multifactorial disorder that requires simultaneous management of both mechanical and functional impairments. Arthroscopic anatomical repair of the lateral ligament complex demonstrates clinical outcomes comparable to those of open surgery while providing the advantages of reduced soft tissue trauma, a lower rate of neurological complications, and faster postoperative rehabilitation.
- 11 September 2026
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 6,p. 182-190
Open AccessCHRONIC ANKLE INSTABILITY: A REVIEW OF MODERN APPROACHES TO DIAGNOSIS AND TREATMENT
Introduction. Ligamentous injuries of the ankle joint are among the most common sports- and work-related musculoskeletal injuries. Despite advances in the management of acute ankle sprains, 25–40% of patients subsequently develop chronic ankle instability (CAI). This condition is characterized by recurrent ankle sprains, persistent pain, reduced range of motion, and impaired proprioception, resulting in functional limitations and highlighting the need for a well-defined diagnostic and therapeutic approach.Aim. To conduct a comprehensive analysis of current scientific evidence regarding the pathophysiological mechanisms, differential diagnostic criteria, and clinical outcomes of conservative and surgical treatment strategies for patients with chronic post-traumatic ankle instability.Materials and methods. This review analyzes the anatomical and biomechanical characteristics of the lateral ligament complex, including the anterior talofibular (ATFL), calcaneofibular (CFL), and posterior talofibular (PTFL) ligaments. It also examines the physiological basis for classifying CAI into mechanical instability (structural ligament insufficiency) and functional instability (neuromuscular deficits and impaired coordination).Results. Comprehensive clinical evaluation should combine specific manual stress tests with advanced imaging modalities. Ultrasonography and magnetic resonance imaging demonstrate high diagnostic accuracy for assessing ligament integrity and detecting associated intra-articular lesions, including synovitis, osteochondral defects, and impingement syndrome. A differentiated treatment strategy is recommended: structured conservative rehabilitation lasting at least 3 months is effective for patients with functional instability, whereas persistent mechanical instability requires surgical stabilization. Surgical techniques have evolved from the conventional open Broström–Gould procedure to contemporary minimally invasive arthroscopic repair and synthetic tape augmentation.Conclusions. Chronic ankle instability is a multifactorial disorder that requires simultaneous management of both mechanical and functional impairments. Arthroscopic anatomical repair of the lateral ligament complex demonstrates clinical outcomes comparable to those of open surgery while providing the advantages of reduced soft tissue trauma, a lower rate of neurological complications, and faster postoperative rehabilitation.
- Open Access
- 30 July 2026
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 2026 (7) , 1633-1645
Tibiofibular stabilization in patients with ankle and posterior malleolus fractures : a systematic review and meta-analysis
Aim: To compare the functional outcomes and the frequency of use of distal tibiofibular stabilization (TFS) in patients with ankle fractures involving the posterior malleolus (PM). Materials and Methods: A systematic literature search was conducted in MEDLINE (PubMed), Scopus and the Cochrane Library databases in accordance with the PICOS and PRISMA guidelines. Studies included in the meta-analysis were analyzed using the Cochrane RevMan software. 20 studies were selected for qualitative analysis and 18 for quantitative analysis, and included 2179 patients. Functional outcomes according to the AOFAS scale in patients with ankle fractures and PM fractures treated with TFS were not statistically different from the control group (MD = 1.00; 95% CI [-4.70, 6.70]; p = .073, I²=87%). A significant decrease in the use of TFS was found in patients after fixation of the PM (OR = 3.77; 95% CI [2.13, 6.69]; p < 0.00001, I²=78%) and in patients who had PM fixation with a buttress plate (OR = 0.44; 95% CI [0.25, 0.79]; p = 0.006, I²=0%). Conclusions: The use of additional TFS after fixation of the PM does not affect the functional outcomes of treatment of patients with ankle fractures. Fixation of the PM fragment significantly reduces the need for TFS. Open repositioning and osteosynthesis of the PM by a buttress plate reduces the need for TFS as compared to screws.
- 30 July 2026
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 2026 (7) , 1633-1645
Open AccessTibiofibular stabilization in patients with ankle and posterior malleolus fractures : a systematic review and meta-analysis
Aim: To compare the functional outcomes and the frequency of use of distal tibiofibular stabilization (TFS) in patients with ankle fractures involving the posterior malleolus (PM). Materials and Methods: A systematic literature search was conducted in MEDLINE (PubMed), Scopus and the Cochrane Library databases in accordance with the PICOS and PRISMA guidelines. Studies included in the meta-analysis were analyzed using the Cochrane RevMan software. 20 studies were selected for qualitative analysis and 18 for quantitative analysis, and included 2179 patients. Functional outcomes according to the AOFAS scale in patients with ankle fractures and PM fractures treated with TFS were not statistically different from the control group (MD = 1.00; 95% CI [-4.70, 6.70]; p = .073, I²=87%). A significant decrease in the use of TFS was found in patients after fixation of the PM (OR = 3.77; 95% CI [2.13, 6.69]; p < 0.00001, I²=78%) and in patients who had PM fixation with a buttress plate (OR = 0.44; 95% CI [0.25, 0.79]; p = 0.006, I²=0%). Conclusions: The use of additional TFS after fixation of the PM does not affect the functional outcomes of treatment of patients with ankle fractures. Fixation of the PM fragment significantly reduces the need for TFS. Open repositioning and osteosynthesis of the PM by a buttress plate reduces the need for TFS as compared to screws.
- Open Access
- 30 March 2026
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 22 (2) , 176-183
Primary arthrodesis as a treatment of choice for “unsalvageable” pilon fractures
Background. The treatment of comminuted AO/OTA type 43C3 pilon fractures remains a clinical challenge. Attempts at open reduction and internal fixation (ORIF) in cases with significant articular surface destruction and severe soft tissue damage (“unsalvageable” fractures) are associated with high complication rates and poor outcomes, combined with a significant duration, multi-stage treatment and significant socio-economic costs. The search for optimal treatment strategies in the most severe injuries remains relevant. Objective: to compare clinical and functional outcomes of primary ankle arthrodesis (main, prospective group) with staged ORIF results (comparison, retrospective group) in patients with severe type 43C3 pilon fractures, and to validate criteria for identifying “unsalvageable” cases. Materials and methods. A prospective-retrospective comparative study was conducted. Group 1 (comparison, retrospective) included 34 patients treated from 2018 to 2022 who underwent staged ORIF to possibly restore the anatomy of the joint and preserve its function. Group 2 (main, prospective) consisted of 30 patients treated from 2022 to 2024 who underwent primary arthrodesis based on “unsalvageable” fracture criteria. These criteria included articular surface destruction (> 3 major fragments and/or central impaction > 5 mm), bone loss (> 25 % volume), and severe soft tissue damage (Gustilo-Anderson II–IIIA). Primary endpoints were nonunion and deep infection rates. Secondary endpoints were AOFAS functional score at 12 months and time to full weight-bearing. Statistical analysis was performed using Fisher’s exact test and Mann-Whitney test (p < 0.05). Results. In the retrospective ORIF group, nonunion rate was 11.8 % and deep infection rate was 17.6 %. In the prospective arthrodesis group, fusion was achieved in 93.3 % of cases with a nonunion rate of 6.7 % (p = 0.674). Deep infection occurred in 6.7 % of patients versus 17.6 % in the comparison group (p = 0.265). Mean AOFAS score at 12 months was 79.2 ± 11.8 (95% CI: 74.8–83.6) in the arthrodesis group versus 75.5 ± 15.0 (95% CI: 70.3–80.7) in the ORIF group (p = 0.284). Time to full weight-bearing was significantly shorter in the arthrodesis group (9.8 ± 2.3 weeks versus 16.8 ± 4.1 weeks; p < 0.001). Reoperation rate was 10.0 % (95% CI: 2.1–26.5) in the arthrodesis group versus 41.2 % (95% CI: 24.7–59.3) in the ORIF group (p = 0.006). Conclusions. For patients with “unsalvageable” type 43C3 pilon fractures, primary arthrodesis demonstrated lower risk of infectious complications, significantly faster recovery of weight-bearing function, and reduced need for reoperations compared to ORIF. The developed “unsalvageability” criteria allow for effective identification of patients indicated for primary arthrodesis.
- 30 March 2026
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 22 (2) , 176-183
Open AccessPrimary arthrodesis as a treatment of choice for “unsalvageable” pilon fractures
Background. The treatment of comminuted AO/OTA type 43C3 pilon fractures remains a clinical challenge. Attempts at open reduction and internal fixation (ORIF) in cases with significant articular surface destruction and severe soft tissue damage (“unsalvageable” fractures) are associated with high complication rates and poor outcomes, combined with a significant duration, multi-stage treatment and significant socio-economic costs. The search for optimal treatment strategies in the most severe injuries remains relevant. Objective: to compare clinical and functional outcomes of primary ankle arthrodesis (main, prospective group) with staged ORIF results (comparison, retrospective group) in patients with severe type 43C3 pilon fractures, and to validate criteria for identifying “unsalvageable” cases. Materials and methods. A prospective-retrospective comparative study was conducted. Group 1 (comparison, retrospective) included 34 patients treated from 2018 to 2022 who underwent staged ORIF to possibly restore the anatomy of the joint and preserve its function. Group 2 (main, prospective) consisted of 30 patients treated from 2022 to 2024 who underwent primary arthrodesis based on “unsalvageable” fracture criteria. These criteria included articular surface destruction (> 3 major fragments and/or central impaction > 5 mm), bone loss (> 25 % volume), and severe soft tissue damage (Gustilo-Anderson II–IIIA). Primary endpoints were nonunion and deep infection rates. Secondary endpoints were AOFAS functional score at 12 months and time to full weight-bearing. Statistical analysis was performed using Fisher’s exact test and Mann-Whitney test (p < 0.05). Results. In the retrospective ORIF group, nonunion rate was 11.8 % and deep infection rate was 17.6 %. In the prospective arthrodesis group, fusion was achieved in 93.3 % of cases with a nonunion rate of 6.7 % (p = 0.674). Deep infection occurred in 6.7 % of patients versus 17.6 % in the comparison group (p = 0.265). Mean AOFAS score at 12 months was 79.2 ± 11.8 (95% CI: 74.8–83.6) in the arthrodesis group versus 75.5 ± 15.0 (95% CI: 70.3–80.7) in the ORIF group (p = 0.284). Time to full weight-bearing was significantly shorter in the arthrodesis group (9.8 ± 2.3 weeks versus 16.8 ± 4.1 weeks; p < 0.001). Reoperation rate was 10.0 % (95% CI: 2.1–26.5) in the arthrodesis group versus 41.2 % (95% CI: 24.7–59.3) in the ORIF group (p = 0.006). Conclusions. For patients with “unsalvageable” type 43C3 pilon fractures, primary arthrodesis demonstrated lower risk of infectious complications, significantly faster recovery of weight-bearing function, and reduced need for reoperations compared to ORIF. The developed “unsalvageability” criteria allow for effective identification of patients indicated for primary arthrodesis.
- Open Access
- 28 December 2025
- Published by Group of Companies Med Expert, LLC in Paediatric Surgery. Ukraine
- No. 4(89),p. 41-46
Calcaneal lengthening osteotomy in the treatment of flexible flatfoot in children
Aim - to analyze the skialogical, functional, and clinical results of calcaneal lengthening osteotomy in children with flexible flatfoot (FF). Material and methods. The retrospective study includes 10 patients (17 cases) with FF who underwent calcaneal lengthening osteotomy by the Evans-Mosca technique. All patients had the shortening of the m. triceps surae. The age of patients ranged from 8 to 16 years (mean 12±0.7 years); there were 9 boys and 1 girl. Evaluation of the results was carried out on the dynamics of vertical and horizontal talo-1st-metatarsal angles (TMA), os calcis inclination angle (CIA), AOFAS scale (hindfoot and ankle), Foot Function Index (17-I FFI, Italian version), VAS (pain) in terms of 2 to 4 years. Results. The operation caused a pronounced cosmetic, radiological, and functional effect. All patients and their parents were satisfied with the result of the surgery. There is an improvement in radiological parameters on average: vertical TMA from 21,9 to 1,9°; horizontal TMA from 21,1 to 3°; CIA from 6,8 to 15,3°. The dynamics of the foot function by average: increasing by AOFAS scale from 69,3 to 95,1; improvements for FFI from 14,9 to 2%; reduction of pain by VAS from 3,8 to 0,8. Effective foot extension increased from 0,5 to 8,9°. The difference between the averages was significant (p˂0,001). Conclusion. Os calcis lengthening osteotomy is an effective operation in the treatment of symptomatic FF in children, which provides a significant reduction in pain, good clinical and radiological results. The advantages of os calcis lengthening osteotomy are simple surgical techniques and a low risk of neurovascular complications. The study was conducted in accordance with the Declaration of Helsinki. The protocol was approved by the Local Ethics Committee. Written informed consent was obtained from the children’s legal guardians. The authors declare no conflict of interest.
- 28 December 2025
- Published by Group of Companies Med Expert, LLC in Paediatric Surgery. Ukraine
- No. 4(89),p. 41-46
Open AccessCalcaneal lengthening osteotomy in the treatment of flexible flatfoot in children
Aim - to analyze the skialogical, functional, and clinical results of calcaneal lengthening osteotomy in children with flexible flatfoot (FF). Material and methods. The retrospective study includes 10 patients (17 cases) with FF who underwent calcaneal lengthening osteotomy by the Evans-Mosca technique. All patients had the shortening of the m. triceps surae. The age of patients ranged from 8 to 16 years (mean 12±0.7 years); there were 9 boys and 1 girl. Evaluation of the results was carried out on the dynamics of vertical and horizontal talo-1st-metatarsal angles (TMA), os calcis inclination angle (CIA), AOFAS scale (hindfoot and ankle), Foot Function Index (17-I FFI, Italian version), VAS (pain) in terms of 2 to 4 years. Results. The operation caused a pronounced cosmetic, radiological, and functional effect. All patients and their parents were satisfied with the result of the surgery. There is an improvement in radiological parameters on average: vertical TMA from 21,9 to 1,9°; horizontal TMA from 21,1 to 3°; CIA from 6,8 to 15,3°. The dynamics of the foot function by average: increasing by AOFAS scale from 69,3 to 95,1; improvements for FFI from 14,9 to 2%; reduction of pain by VAS from 3,8 to 0,8. Effective foot extension increased from 0,5 to 8,9°. The difference between the averages was significant (p˂0,001). Conclusion. Os calcis lengthening osteotomy is an effective operation in the treatment of symptomatic FF in children, which provides a significant reduction in pain, good clinical and radiological results. The advantages of os calcis lengthening osteotomy are simple surgical techniques and a low risk of neurovascular complications. The study was conducted in accordance with the Declaration of Helsinki. The protocol was approved by the Local Ethics Committee. Written informed consent was obtained from the children’s legal guardians. The authors declare no conflict of interest.
- Open Access
- 21 December 2025
- Published by Orthopaedica, Traumatology, and Prosthetics in ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS
- No. 4
PROGNOSTIC FACTORS IN THE TREATMENT OF FOCAL OSTEOCHONDRAL LESIONS OF THE KNEE AND ANKLE
Osteochondral lesions of the knee and ankle joints are a common pathology that often results in decreased physical activity and early osteoarthritis. Despite the wide range of available surgical techniques, their efficacy varies considerably. Identifying prognostic factors is essential for optimizing treatment strategies. Studying and taking into account the factors that determine the outcome of treatment is a relevant issue in terms of improving the efficiency of providing care to patients in this category. Objective. To identify prognostic factors and informativeness coefficients in treatment of patients with osteochondral lesions. Methods. A retrospective study included 390 patients with focal osteochondral lesions treated with arthroscopic debridement, microfracture, drilling, or osteochondral autograft transplantation. Treatment effectiveness was evaluated using 21 clinical and morphological parameters and functional scores (Lysholm, AOFAS, SF-36, NRS) at 12–36-month follow-up. Statistical analysis included Bayesian probabilistic methods adapted for clinical research, Kulback’s information measure to assess information coefficients, and a heterogeneous sequential procedure based on Wald analysis to determine prognostic coefficients. Results. Positive outcomes were observed in 284 patients (72.8 %), while 106 (27.2 %) had negative outcomes. Key prognostic factors included age, body mass index, lesion size, Kellgren & Lawrence osteoarthritis stage, lesion chronicity, limb axis deviations, and prior surgical history. Conclusions. The identified prognostic and informativeness coefficients have practical value for establishing an individualized approach to selecting the optimal treatment strategy and improving long-term outcomes.
- 21 December 2025
- Published by Orthopaedica, Traumatology, and Prosthetics in ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS
- No. 4
Open AccessPROGNOSTIC FACTORS IN THE TREATMENT OF FOCAL OSTEOCHONDRAL LESIONS OF THE KNEE AND ANKLE
Osteochondral lesions of the knee and ankle joints are a common pathology that often results in decreased physical activity and early osteoarthritis. Despite the wide range of available surgical techniques, their efficacy varies considerably. Identifying prognostic factors is essential for optimizing treatment strategies. Studying and taking into account the factors that determine the outcome of treatment is a relevant issue in terms of improving the efficiency of providing care to patients in this category. Objective. To identify prognostic factors and informativeness coefficients in treatment of patients with osteochondral lesions. Methods. A retrospective study included 390 patients with focal osteochondral lesions treated with arthroscopic debridement, microfracture, drilling, or osteochondral autograft transplantation. Treatment effectiveness was evaluated using 21 clinical and morphological parameters and functional scores (Lysholm, AOFAS, SF-36, NRS) at 12–36-month follow-up. Statistical analysis included Bayesian probabilistic methods adapted for clinical research, Kulback’s information measure to assess information coefficients, and a heterogeneous sequential procedure based on Wald analysis to determine prognostic coefficients. Results. Positive outcomes were observed in 284 patients (72.8 %), while 106 (27.2 %) had negative outcomes. Key prognostic factors included age, body mass index, lesion size, Kellgren & Lawrence osteoarthritis stage, lesion chronicity, limb axis deviations, and prior surgical history. Conclusions. The identified prognostic and informativeness coefficients have practical value for establishing an individualized approach to selecting the optimal treatment strategy and improving long-term outcomes.
- Open Access
- 20 December 2025
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 21 (8) , 808-818
Treatment strategy for patients with osteochondral lesions of the knee and ankle joints
Background. Intraarticular osteochondral lesions of the knee and ankle joints represent a significant clinical challenge due to their limited capacity for spontaneous regeneration and the risk of progressive osteoarthritis. The absence of a standardized treatment algorithm that accounts for prognostic factors, alongside the lack of individualized outcome prediction, negatively affects both short- and long-term treatment results. This study aimed to evaluate the outcomes of patients with osteochondral lesions of the knee and ankle joints treated using a newly developed algorithm combined with a clinical outcome prediction system. Materials and methods. A comparative clinical analysis was performed involving a control group of 390 patients (retrospective evaluation) and a main group of 98 patients in whom the developed treatment algorithm and prediction system were applied. All patients underwent assessment before treatment using the Lysholm, AOFAS scales, SF-36, and NRS, followed by reassessment at 6, 12, and 24–36 months. Statistical significance was determined at p < 0.05 using the test or Fisher’s exact test. Prognostic factor significance was evaluated by calculating odds ratios with 95 % confidence intervals. Results. When using the treatment algorithm and prediction system, the positive outcome in the main group was 90.8 %, compared to 72.8 % in the control group. After 24–36 months, functional scores on the Lysholm and AOFAS scales were higher in the main group (p < 0.001). The quality of life of patients on the SF-36 improved in 98 % of cases, and the level of pain syndrome decreased to minimum values in 95.9 % of patients. Conclusions. The developed treatment system allows for an individualized approach to treatment, which significantly increases its effectiveness, ensures the stability of the results obtained, and improves the functional indicators and quality of life of patients.
- 20 December 2025
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 21 (8) , 808-818
Open AccessTreatment strategy for patients with osteochondral lesions of the knee and ankle joints
Background. Intraarticular osteochondral lesions of the knee and ankle joints represent a significant clinical challenge due to their limited capacity for spontaneous regeneration and the risk of progressive osteoarthritis. The absence of a standardized treatment algorithm that accounts for prognostic factors, alongside the lack of individualized outcome prediction, negatively affects both short- and long-term treatment results. This study aimed to evaluate the outcomes of patients with osteochondral lesions of the knee and ankle joints treated using a newly developed algorithm combined with a clinical outcome prediction system. Materials and methods. A comparative clinical analysis was performed involving a control group of 390 patients (retrospective evaluation) and a main group of 98 patients in whom the developed treatment algorithm and prediction system were applied. All patients underwent assessment before treatment using the Lysholm, AOFAS scales, SF-36, and NRS, followed by reassessment at 6, 12, and 24–36 months. Statistical significance was determined at p < 0.05 using the test or Fisher’s exact test. Prognostic factor significance was evaluated by calculating odds ratios with 95 % confidence intervals. Results. When using the treatment algorithm and prediction system, the positive outcome in the main group was 90.8 %, compared to 72.8 % in the control group. After 24–36 months, functional scores on the Lysholm and AOFAS scales were higher in the main group (p < 0.001). The quality of life of patients on the SF-36 improved in 98 % of cases, and the level of pain syndrome decreased to minimum values in 95.9 % of patients. Conclusions. The developed treatment system allows for an individualized approach to treatment, which significantly increases its effectiveness, ensures the stability of the results obtained, and improves the functional indicators and quality of life of patients.
- Open Access
- 24 September 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 3,p. 150-158
Non-acidic NSAIDs in the Treatment of Post-traumatic Persistent Synovitis of the Knee Joint: Safety and Efficacy
Persistent inflammation is a long-term inflammatory process that persists even in the absence of overt clinical symptoms. Such inflammation can occur and persist in a joint with various types of injuries and especially in patients who have concomitant osteoarthritis with an inflammatory phenotype / endotype. The objective: to evaluate the efficacy and safety of nabumetone in the treatment of patients with persistent synovitis (lasting more than 3 weeks) in the setting of acute and degenerative knee meniscal injuries which were treated surgically. Materials and methods. The clinical study was designed as a randomized, prospective, comparative study. Two groups were formed: the main group – MG (n = 30 patients) and the comparison group – CG (n = 30 patients). The average age of the patients was 44.3 ± 2.7 years. There were 41 female patients (68%), 19 male (32%) patients. During the X-ray examination with functional load, signs of early stages of osteoarthritis from 1st to 2nd stages according to the Kellgren–Lawrence classification were determined in both groups. The study included patients with degenerative and acute injuries of the meniscus of the knee joint, which were treated surgically (arthroscopically), in whom persistent long-term synovitis was observed in the postoperative period after a standard course of postoperative drug therapy and rehabilitation, which was determined during clinical and ultrasound examinations within 3 weeks after surgery. In the MG, in order to eliminate inflammation, patients were prescribed nabumetone in a daily dose of 1000 mg (500 mg 2 times a day) for 10 days. Subsequently, in order to assess the effectiveness of treatment and the stability of the clinical effect, patients were prescribed the same nonsteroidal anti-inflammatory drug (NSAID) in a dose of 500 mg 1 time per day only “on demand” for a period of up to 1 month. In the CG, patients were prescribed the classic non-prescription NSAID ibuprofen in a dose of 400 mg 2 times a day for a similar period of time (10 days). Subsequently, similarly to the MG, the patients were prescribed the same NSAID in a dose of 400 mg 1 time per day “on demand” for 1 month. The analysis of efficacy and safety was performed before treatment, in 10 days and 1 month after its start based on the assessment of the following criteria and parameters: pain intensity according to visual analogue scale (VAS), functional status according to the Lisholm scale, periarticular edema according to the Doyle index, average weekly need for NSAIDs after a 10-day course of treatment, assessment of the safety and tolerability of the NSAIDs. Results. After 10 days in both groups a good analgesic effect was found, which was according to VAS 19.4 ± 0.7 vs 22.9 ± 0.4, with no difference between the groups (p = 0.089). In the next 3 weeks, patients in the MG had a stable analgesic effect and no need for nabumetone “on demand”. At the same time, in the CG, on the contrary, a tendency to a gradual increased pain intensity was determined 15.1 ± 0.1 vs 23.7 ± 0.3, the difference between the groups was significant (p = 0.012), and the need for ibuprofen “on demand” was 844.6 ± 15.2 mg per week (≈ 400 mg – 2 times a week). The Lisholm score showed a better functional outcome in the MG both after 10 days: 86.9 ± 0.8 vs 77.1 ± 0.3 (p = 0.029) and after 1 month: 94.8 ± 0.8 vs 78.9 ± 0.3 (p = 0.034). The Doyle index score also showed a statistical difference between the groups both after 10 days: 12.8 ± 0.6 vs 15.1 ± 0.4 (p = 0.048) and after 1 month: 8.6 ± 0.7 vs 16.3 ± 0.4 (p = 0.016). At the same time, patients in the CG continued to use NSAIDs (ibuprofen) in an average weekly dose of 844.6 ± 15.2 mg (at least 400 mg – 2 times a week), while the patients in the MG did not need to take NSAIDs “on demand”. There was no difference in the number of patients with undesirable side effects in the groups: 5 (16%) vs 7 (23%) (p > 0.05). However, in terms of the frequency of individual side effects, it was found that pain and discomfort in the epigastrium, as well as a feeling of nausea, occurred less often in the MG: 6% vs 23% and 6% vs 20% (p < 0.05). Conclusions. An important element of the treatment of patients with post-traumatic persistent synovitis on the background of osteoarthritis with an inflammatory endotype / phenotype is the rational choice of a synovial membrane-tropic, safe anti-inflammatory drug in an adequate dose and an effective course, which may be longer than the standard one. The non-acidic NSAID nabumetone meets these requirements.
- 24 September 2025
- Published by Professional Event, LLC in Family medicine. European practices
- No. 3,p. 150-158
Open AccessNon-acidic NSAIDs in the Treatment of Post-traumatic Persistent Synovitis of the Knee Joint: Safety and Efficacy
Persistent inflammation is a long-term inflammatory process that persists even in the absence of overt clinical symptoms. Such inflammation can occur and persist in a joint with various types of injuries and especially in patients who have concomitant osteoarthritis with an inflammatory phenotype / endotype. The objective: to evaluate the efficacy and safety of nabumetone in the treatment of patients with persistent synovitis (lasting more than 3 weeks) in the setting of acute and degenerative knee meniscal injuries which were treated surgically. Materials and methods. The clinical study was designed as a randomized, prospective, comparative study. Two groups were formed: the main group – MG (n = 30 patients) and the comparison group – CG (n = 30 patients). The average age of the patients was 44.3 ± 2.7 years. There were 41 female patients (68%), 19 male (32%) patients. During the X-ray examination with functional load, signs of early stages of osteoarthritis from 1st to 2nd stages according to the Kellgren–Lawrence classification were determined in both groups. The study included patients with degenerative and acute injuries of the meniscus of the knee joint, which were treated surgically (arthroscopically), in whom persistent long-term synovitis was observed in the postoperative period after a standard course of postoperative drug therapy and rehabilitation, which was determined during clinical and ultrasound examinations within 3 weeks after surgery. In the MG, in order to eliminate inflammation, patients were prescribed nabumetone in a daily dose of 1000 mg (500 mg 2 times a day) for 10 days. Subsequently, in order to assess the effectiveness of treatment and the stability of the clinical effect, patients were prescribed the same nonsteroidal anti-inflammatory drug (NSAID) in a dose of 500 mg 1 time per day only “on demand” for a period of up to 1 month. In the CG, patients were prescribed the classic non-prescription NSAID ibuprofen in a dose of 400 mg 2 times a day for a similar period of time (10 days). Subsequently, similarly to the MG, the patients were prescribed the same NSAID in a dose of 400 mg 1 time per day “on demand” for 1 month. The analysis of efficacy and safety was performed before treatment, in 10 days and 1 month after its start based on the assessment of the following criteria and parameters: pain intensity according to visual analogue scale (VAS), functional status according to the Lisholm scale, periarticular edema according to the Doyle index, average weekly need for NSAIDs after a 10-day course of treatment, assessment of the safety and tolerability of the NSAIDs. Results. After 10 days in both groups a good analgesic effect was found, which was according to VAS 19.4 ± 0.7 vs 22.9 ± 0.4, with no difference between the groups (p = 0.089). In the next 3 weeks, patients in the MG had a stable analgesic effect and no need for nabumetone “on demand”. At the same time, in the CG, on the contrary, a tendency to a gradual increased pain intensity was determined 15.1 ± 0.1 vs 23.7 ± 0.3, the difference between the groups was significant (p = 0.012), and the need for ibuprofen “on demand” was 844.6 ± 15.2 mg per week (≈ 400 mg – 2 times a week). The Lisholm score showed a better functional outcome in the MG both after 10 days: 86.9 ± 0.8 vs 77.1 ± 0.3 (p = 0.029) and after 1 month: 94.8 ± 0.8 vs 78.9 ± 0.3 (p = 0.034). The Doyle index score also showed a statistical difference between the groups both after 10 days: 12.8 ± 0.6 vs 15.1 ± 0.4 (p = 0.048) and after 1 month: 8.6 ± 0.7 vs 16.3 ± 0.4 (p = 0.016). At the same time, patients in the CG continued to use NSAIDs (ibuprofen) in an average weekly dose of 844.6 ± 15.2 mg (at least 400 mg – 2 times a week), while the patients in the MG did not need to take NSAIDs “on demand”. There was no difference in the number of patients with undesirable side effects in the groups: 5 (16%) vs 7 (23%) (p > 0.05). However, in terms of the frequency of individual side effects, it was found that pain and discomfort in the epigastrium, as well as a feeling of nausea, occurred less often in the MG: 6% vs 23% and 6% vs 20% (p < 0.05). Conclusions. An important element of the treatment of patients with post-traumatic persistent synovitis on the background of osteoarthritis with an inflammatory endotype / phenotype is the rational choice of a synovial membrane-tropic, safe anti-inflammatory drug in an adequate dose and an effective course, which may be longer than the standard one. The non-acidic NSAID nabumetone meets these requirements.
- Open Access
- 15 September 2025
- Published by Publishing House Zaslavsky in PAIN, JOINTS, SPINE
- Vol. 15 (3) , 126-133
Bone marrow mesenchymal stem cells in the treatment of patients with knee osteoarthritis
Background. The use of mesenchymal stem cells (MSCs) in joint lesions is an extremely controversial issue due to the presence of numerous unresolved problems both in understanding the biological properties of MSCs and in terms of their practical application. The purpose of the study was to evaluate the functional results and clinical efficacy of using autologous MSCs obtained from bone marrow in the treatment of patients with post-traumatic osteoarthritis (PTOA) of the knee joint (KS) in the early stages, during a six-month observation period. Materials and methods. 28 patients with PTOA of the knee joint of stage I–II according to Kellgren-Lawrence were treated. Among them, 11 (39.0 %) were men and 17 (61.0 %) were women, the average age was 44.80 ± 10.95 years. The average period after the injury was 7.8 ± 0.5 years. MSCs were harvested from the iliac wing and cultured in a biotechnology laboratory. Intra-articular injection was performed once during exacerbation of PTOA (50 million cells). Efficacy was assessed after 6 months. Evaluation criteria: need for NSAIDs, number of exacerbations of PTOA; functional status of the joint according to Lisholm and WOMAC. Pain syndrome was assessed using the visual analog scale (VAS), quality of life according to the 36-Item Short Form Survey (SF-36) scale. Results. After 6 months after the use of MSC, positive dynamics were obtained in all categories of assessment of the functional status of the knee joint: pain according to VAS decreased to 2.2 ± 0.3 (p < 0.05); functional activity according to the Lisholm scale increased by 29.4 % (p < 0.01), the total WOMAC index decreased by 51.7 % (p < 0.01); the quality of life index increased by 57.7 ± 9.3 % when assessed using SF-36 (p < 0.01). In addition, during the 6-month clinical observation period following the use of MSCs, a significant decrease in the frequency of exacerbations of PTOA compared to the previous 6-month period and a decrease in the need for NSAIDs were demonstrated. Conclusion. MSCs are an effective and safe method of treating PTOA of the knee in the early stages, accompanied by a significant decrease in pain syndrome indicators, improvement in joint function and quality of life, as well as a decrease in the number of PTOA exacerbations and the need for NSAIDs for at least 6 months.
- 15 September 2025
- Published by Publishing House Zaslavsky in PAIN, JOINTS, SPINE
- Vol. 15 (3) , 126-133
Open AccessBone marrow mesenchymal stem cells in the treatment of patients with knee osteoarthritis
Background. The use of mesenchymal stem cells (MSCs) in joint lesions is an extremely controversial issue due to the presence of numerous unresolved problems both in understanding the biological properties of MSCs and in terms of their practical application. The purpose of the study was to evaluate the functional results and clinical efficacy of using autologous MSCs obtained from bone marrow in the treatment of patients with post-traumatic osteoarthritis (PTOA) of the knee joint (KS) in the early stages, during a six-month observation period. Materials and methods. 28 patients with PTOA of the knee joint of stage I–II according to Kellgren-Lawrence were treated. Among them, 11 (39.0 %) were men and 17 (61.0 %) were women, the average age was 44.80 ± 10.95 years. The average period after the injury was 7.8 ± 0.5 years. MSCs were harvested from the iliac wing and cultured in a biotechnology laboratory. Intra-articular injection was performed once during exacerbation of PTOA (50 million cells). Efficacy was assessed after 6 months. Evaluation criteria: need for NSAIDs, number of exacerbations of PTOA; functional status of the joint according to Lisholm and WOMAC. Pain syndrome was assessed using the visual analog scale (VAS), quality of life according to the 36-Item Short Form Survey (SF-36) scale. Results. After 6 months after the use of MSC, positive dynamics were obtained in all categories of assessment of the functional status of the knee joint: pain according to VAS decreased to 2.2 ± 0.3 (p < 0.05); functional activity according to the Lisholm scale increased by 29.4 % (p < 0.01), the total WOMAC index decreased by 51.7 % (p < 0.01); the quality of life index increased by 57.7 ± 9.3 % when assessed using SF-36 (p < 0.01). In addition, during the 6-month clinical observation period following the use of MSCs, a significant decrease in the frequency of exacerbations of PTOA compared to the previous 6-month period and a decrease in the need for NSAIDs were demonstrated. Conclusion. MSCs are an effective and safe method of treating PTOA of the knee in the early stages, accompanied by a significant decrease in pain syndrome indicators, improvement in joint function and quality of life, as well as a decrease in the number of PTOA exacerbations and the need for NSAIDs for at least 6 months.